Rosalin Cooper

1.5k total citations
24 papers, 951 citations indexed

About

Rosalin Cooper is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Rosalin Cooper has authored 24 papers receiving a total of 951 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Rosalin Cooper's work include Cancer Immunotherapy and Biomarkers (4 papers), Acute Myeloid Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). Rosalin Cooper is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Acute Myeloid Leukemia Research (3 papers) and CAR-T cell therapy research (3 papers). Rosalin Cooper collaborates with scholars based in United Kingdom, Italy and Canada. Rosalin Cooper's co-authors include R. T. Chlebowski, Matthew L. Baum, I. Craig Henderson, Kasper Langebjerg Andersen, Martin D. Abeloff, O Abe, G. Bonadonna, J. Cuzick, Aman U. Buzdar and Paul P. Carbone and has published in prestigious journals such as Nature Medicine, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Rosalin Cooper

20 papers receiving 916 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rosalin Cooper United Kingdom 10 499 292 221 188 174 24 951
Whay Kuang Chia Singapore 13 386 0.8× 147 0.5× 48 0.2× 190 1.0× 122 0.7× 19 785
Dingli Song China 14 429 0.9× 283 1.0× 106 0.5× 81 0.4× 371 2.1× 33 1.2k
Marisa Cañadas‐Garre Spain 19 256 0.5× 192 0.7× 95 0.4× 101 0.5× 435 2.5× 44 1.0k
Gianmaria Miolo Italy 17 399 0.8× 196 0.7× 171 0.8× 125 0.7× 423 2.4× 86 996
Nathan Enas United States 16 492 1.0× 174 0.6× 114 0.5× 77 0.4× 358 2.1× 25 1.4k
Lissandra Dal Lago Belgium 18 1.2k 2.3× 219 0.8× 352 1.6× 92 0.5× 305 1.8× 54 1.7k
Laura Kruper United States 18 825 1.7× 580 2.0× 106 0.5× 289 1.5× 300 1.7× 66 1.7k
Matthew D. Burstein United States 7 640 1.3× 492 1.7× 76 0.3× 117 0.6× 363 2.1× 12 1.1k
José E. Alés‐Martínez Spain 9 469 0.9× 343 1.2× 479 2.2× 75 0.4× 155 0.9× 20 924
Phuong K. Morrow United States 24 1.0k 2.1× 283 1.0× 217 1.0× 125 0.7× 525 3.0× 65 1.8k

Countries citing papers authored by Rosalin Cooper

Since Specialization
Citations

This map shows the geographic impact of Rosalin Cooper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalin Cooper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalin Cooper more than expected).

Fields of papers citing papers by Rosalin Cooper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalin Cooper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalin Cooper. The network helps show where Rosalin Cooper may publish in the future.

Co-authorship network of co-authors of Rosalin Cooper

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalin Cooper. A scholar is included among the top collaborators of Rosalin Cooper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalin Cooper. Rosalin Cooper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thomas, Emily, et al.. (2025). Entering the era of spatial transcriptomics: opportunities and challenges for pathology. Diagnostic histopathology. 31(5). 257–266. 1 indexed citations
2.
Cooper, Rosalin, et al.. (2025). Artificial intelligence in haematopathology: current perspective and future directions. Diagnostic histopathology. 31(5). 267–276. 2 indexed citations
3.
Thomas, Emily, Ka Ho Tam, Ruoyu Wang, et al.. (2025). Reticulin‐Free Quantitation of Bone Marrow Fibrosis in MPNs: Utility and Applications. eJHaem. 6(2). e70005–e70005.
4.
Cooper, Rosalin, et al.. (2024). Spatial transcriptomic approaches for characterising the bone marrow landscape: pitfalls and potential. Leukemia. 39(2). 291–295. 4 indexed citations
5.
Ye, Weiyu, Chelsea Taylor, Rosalin Cooper, et al.. (2024). Severe acute myositis and myocarditis on initiation of 6-weekly pembrolizumab post-COVID-19 mRNA vaccination. Journal for ImmunoTherapy of Cancer. 12(4). e008151–e008151. 2 indexed citations
6.
Cooper, Rosalin, Emily Thomas, Alan King Lun Liu, et al.. (2024). Mapping the Human Bone Marrow in Myeloproliferative Neoplasia Using Spatial Transcriptomics. Blood. 144(Supplement 1). 876–876.
8.
Browning, Lisa, Rosalin Cooper, Abhisek Ghosh, et al.. (2022). Impact of the transition to digital pathology in a clinical setting on histopathologists in training: experiences and perceived challenges within a UK training region. Journal of Clinical Pathology. 76(10). 712–718. 5 indexed citations
9.
Gilchrist, James J., Seiko Makino, Vivek Naranbhai, et al.. (2022). Natural Killer cells demonstrate distinct eQTL and transcriptome-wide disease associations, highlighting their role in autoimmunity. Nature Communications. 13(1). 4073–4073. 14 indexed citations
10.
Ye, Weiyu, Anna Olsson‐Brown, Robert Watson, et al.. (2021). Checkpoint-blocker-induced autoimmunity is associated with favourable outcome in metastatic melanoma and distinct T-cell expression profiles. British Journal of Cancer. 124(10). 1661–1669. 33 indexed citations
11.
Fairfax, Benjamin P., Chelsea Taylor, Robert Watson, et al.. (2020). Peripheral CD8+ T cell characteristics associated with durable responses to immune checkpoint blockade in patients with metastatic melanoma. Nature Medicine. 26(2). 193–199. 198 indexed citations
12.
Luca, Bogdan, Vincent Moulton, Dylan R. Edwards, et al.. (2020). A novel stratification framework for predicting outcome in patients with prostate cancer. British Journal of Cancer. 122(10). 1467–1476. 7 indexed citations
13.
Cooper, Rosalin, et al.. (2019). Counting Intraepithelial Lymphocytes: A Comparison Between Routine Staining and CD3 Immunohistochemistry. International Journal of Surgical Pathology. 28(4). 367–370. 4 indexed citations
14.
Cooper, Rosalin, Hannah Markham, J M Theaker, et al.. (2017). Primary Clear Cell Microcystic Adenoma of the Sinonasal Cavity: Pathological or Fortuitous Association?. SHILAP Revista de lepidopterología. 2017. 1–5. 4 indexed citations
15.
Albain, KS, Andrei Zlobin, Prithi Rajan, et al.. (2011). S1-5: Modulation of Cancer and Stem Cell Biomarkers by the Notch Inhibitor MK-0752 Added to Endocrine Therapy for Early Stage ER+ Breast Cancer.. Cancer Research. 71(24_Supplement). S1–5. 17 indexed citations
16.
Rossiter, K., Pankti Reid, Bashir A. Lwaleed, et al.. (2006). Honey and angiogenesis. ePrints Soton (University of Southampton).
17.
Vaux, Emma, D.J. Taylor, P. Altmann, et al.. (2004). Effects of Carnitine Supplementation on Muscle Metabolism by the Use of Magnetic Resonance Spectroscopy and Near-Infrared Spectroscopy in End-Stage Renal Disease. Nephron Clinical Practice. 97(2). c41–c48. 35 indexed citations
18.
Riley, Alan, et al.. (1987). The Prevalence of Sexual Dysfunction in Male and Female Hypertensive Patients. Sexual and Marital Therapy. 2(2). 131–138. 15 indexed citations
19.
Beilin, Lawrence J., et al.. (1979). Home Blood Pressure Monitoring and Changes in Plasma Catecholamines During Once or Twice Daily Treatment with Atenolol in Patients with Mild Hypertension. Australian and New Zealand Journal of Medicine. 9(4). 374–381. 9 indexed citations
20.
Wittliff, James L., et al.. (1976). Estrogen Receptors and Hormone Dependency in Human Breast Cancer. Breast Cancer. 59–77. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026